Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice.

Activation of the N-methyl-D-aspartate receptor (NMDAR) glycine site has been shown to accelerate adaptive forms of learning that may benefit psychopathologies involving cognitive and perseverative disturbances. In this study, the effects of increasing the brain levels of the endogenous NMDAR glycine site agonist D-serine, through the genetic inactivation of its catabolic enzyme D-amino acid oxidase (DAO), were examined in behavioral tests of learning and memory. In the Morris water maze task (MWM), mice carrying the hypofunctional Dao1(G181R) mutation demonstrated normal acquisition of a single platform location but had substantially improved memory for a new target location in the subsequent reversal phase. Furthermore, Dao1(G181R) mutant animals exhibited an increased rate of extinction in the MWM that was similarly observed following pharmacological administration of D-serine (600 mg/kg) in wild-type C57BL/6J mice. In contextual and cued fear conditioning, no alterations were found in initial associative memory recall; however, extinction of the contextual fear memory was facilitated in mutant animals. Thus, an augmented level of D-serine resulting from reduced DAO activity promotes adaptive learning in response to changing conditions. The NMDAR glycine site and DAO may be promising therapeutic targets to improve cognitive flexibility and inhibitory learning in psychiatric disorders such as schizophrenia and anxiety syndromes.

[1]  Wei Wang,et al.  Bell-shaped D-serine actions on hippocampal long-term depression and spatial memory retrieval. , 2008, Cerebral cortex.

[2]  S. Floresco,et al.  Disruption of AMPA Receptor Endocytosis Impairs the Extinction, but not Acquisition of Learned Fear , 2008, Neuropsychopharmacology.

[3]  J. Krystal,et al.  A Meta-Analysis of D-Cycloserine and the Facilitation of Fear Extinction and Exposure Therapy , 2008, Biological Psychiatry.

[4]  Trevor Archer,et al.  Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility , 2008, Pharmacology Biochemistry and Behavior.

[5]  Eric R. Kandel,et al.  Transgenic Mice Lacking NMDAR-Dependent LTD Exhibit Deficits in Behavioral Flexibility , 2008, Neuron.

[6]  J. Roder,et al.  D-Serine Augments NMDA-NR2B Receptor-Dependent Hippocampal Long-Term Depression and Spatial Reversal Learning , 2008, Neuropsychopharmacology.

[7]  P. Fletcher,et al.  Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1‐targeted mice , 2008, Genes, brain, and behavior.

[8]  Joseph E LeDoux,et al.  Acquisition of Fear Extinction Requires Activation of NR2B-Containing NMDA Receptors in the Lateral Amygdala , 2007, Neuropsychopharmacology.

[9]  M. Matsushita,et al.  A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia , 2007, Biological Psychiatry.

[10]  JaneR . Taylor,et al.  Molecular mechanisms of memory reconsolidation , 2007, Nature Reviews Neuroscience.

[11]  Bruno Giros,et al.  Parallel Loss of Hippocampal LTD and Cognitive Flexibility in a Genetic Model of Hyperdopaminergia , 2007, Neuropsychopharmacology.

[12]  D. Hampson,et al.  Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Karim Nader,et al.  NMDA receptors are critical for unleashing consolidated auditory fear memories , 2006, Nature Neuroscience.

[14]  Rick Richardson,et al.  Effects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work , 2006, Biological Psychiatry.

[15]  J. Mothet,et al.  d-Serine signalling in the brain: friend and foe , 2006, Trends in Neurosciences.

[16]  C. Chiu,et al.  Behavioral and biochemical characterization of a mutant mouse strain lacking d-amino acid oxidase activity and its implications for schizophrenia , 2006, Molecular and Cellular Neuroscience.

[17]  S. Mariotto,et al.  Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells , 2006, Neuroscience Letters.

[18]  C. Palm,et al.  Preferred stereoselective brain uptake of d-serine--a modulator of glutamatergic neurotransmission. , 2005, Nuclear medicine and biology.

[19]  K. Summer,et al.  D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity. , 2005, Chemical research in toxicology.

[20]  J. Roder,et al.  Effects of the rd1 Mutation and Host Strain on Hippocampal Learning in Mice , 2005, Behavior genetics.

[21]  M. Maekawa,et al.  Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase , 2005, Neuroscience Research.

[22]  L. Klomp,et al.  D-amino acids in the central nervous system in health and disease. , 2005, Molecular genetics and metabolism.

[23]  K. Hashimoto,et al.  Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[24]  R. Richardson,et al.  d-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction , 2005, Biological Psychiatry.

[25]  Daniel C. Javitt,et al.  D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia , 2005, Biological Psychiatry.

[26]  M. Millan N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives , 2005, Psychopharmacology.

[27]  R. Panizzutti,et al.  Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination Activity* , 2005, Journal of Biological Chemistry.

[28]  Barbara O Rothbaum,et al.  Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. , 2004, Archives of general psychiatry.

[29]  B. Pouzet,et al.  Spatial Memory Deficits Induced by Perinatal Treatment of Rats with PCP and Reversal Effect of D-Serine , 2004, Neuropsychopharmacology.

[30]  J. Coyle,et al.  The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia , 2004, Psychopharmacology.

[31]  Denise Manahan-Vaughan,et al.  Hippocampal long-term depression and long-term potentiation encode different aspects of novelty acquisition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Barger,et al.  Induction of serine racemase expression and D-serine release from microglia by amyloid β-peptide , 2004, Journal of Neuroinflammation.

[33]  S. Cichon,et al.  Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder , 2004, Molecular Psychiatry.

[34]  R. Joosten,et al.  The NMDA-receptor antagonist MK-801 selectively disrupts reversal learning in rats , 2003, Neuroreport.

[35]  M. Poo,et al.  Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Kenji Hashimoto,et al.  Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. , 2003, Archives of general psychiatry.

[37]  A. Pack,et al.  Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. , 2003, Learning & memory.

[38]  R. Nicoll,et al.  Expression mechanisms underlying long-term potentiation: a postsynaptic view. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[39]  J. Kemp,et al.  Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition , 2003, Neuropharmacology.

[40]  M. Caron,et al.  Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in βArrestin-2 Knock-Out Mice , 2002, The Journal of Neuroscience.

[41]  G. Wong Speed congenics: Applications for transgenic and knock-out mouse strains , 2002, Neuropeptides.

[42]  Hongkui Zeng,et al.  Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory , 2001, Cell.

[43]  R. Konno,et al.  Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-d-aspartate receptor-mediated synaptic transmission in mutant mice lacking d-amino-acid oxidase , 2001, Neuroscience Letters.

[44]  D. Linden,et al.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Belger,et al.  Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions , 2000, Biological Psychiatry.

[46]  E. Shimizu,et al.  Genetic enhancement of learning and memory in mice , 1999, Nature.

[47]  D. Manahan‐Vaughan,et al.  Novelty acquisition is associated with induction of hippocampal long-term depression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R Hen,et al.  5-HT1B Receptor Knock-Out Mice Exhibit Increased Exploratory Activity and Enhanced Spatial Memory Performance in the Morris Water Maze , 1999, The Journal of Neuroscience.

[49]  T. Robbins,et al.  Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage , 1999, Schizophrenia Research.

[50]  P. Holland,et al.  Hippocampus and context in classical conditioning , 1999, Current Opinion in Neurobiology.

[51]  R. Nardacci,et al.  Immunocytochemical localization of d-amino acid oxidase in rat brain , 1999, Journal of neurocytology.

[52]  K N Sheth,et al.  Purification of serine racemase: biosynthesis of the neuromodulator D-serine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Nicholas Lange,et al.  D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.

[54]  Hongjoo J. Lee,et al.  Amygdalar NMDA Receptors are Critical for New Fear Learning in Previously Fear-Conditioned Rats , 1998, The Journal of Neuroscience.

[55]  J. Takahashi,et al.  Automated measurement of mouse freezing behavior and its use for quantitative trait locus analysis of contextual fear conditioning in (BALB/cJ x C57BL/6J)F2 mice. , 1998, Learning & memory.

[56]  S. Snyder,et al.  d-Serine as a Neuromodulator: Regional and Developmental Localizations in Rat Brain Glia Resemble NMDA Receptors , 1997, The Journal of Neuroscience.

[57]  E. Kehoe,et al.  MK-801 protects conditioned responses from extinction in the rabbit nictitating membrane preparation , 1996, Psychobiology.

[58]  K. Wada,et al.  Functional Comparison of d‐Serine and Glycine in Rodents: The Effect on Cloned NMDA Receptors and the Extracellular Concentration , 1995, Journal of neurochemistry.

[59]  S. Snyder,et al.  D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[61]  T. Nishikawa,et al.  Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase , 1993, Neuroscience Letters.

[62]  R. Konno,et al.  A single-base-pair substitution abolishes D-amino-acid oxidase activity in the mouse. , 1992, Biochimica et biophysica acta.

[63]  K. Abe,et al.  Involvement of glycine site associated with the NMDA receptor in hippocampal long-term potentiation and acquisition of spatial memory in rats , 1992, Brain Research.

[64]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[65]  J. D. Clements,et al.  Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor , 1991, Neuron.

[66]  P. Ascher,et al.  Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.

[67]  R. Konno,et al.  Mouse mutant deficient in D-amino acid oxidase activity. , 1983, Genetics.

[68]  James L McGaugh,et al.  The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear , 2003, Hippocampus.

[69]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. , 2002, Nature Reviews Genetics.

[70]  I. Whishaw,et al.  Perseveration on place reversals in spatial swimming pool tasks: Further evidence for place learning in hippocampal rats , 1997, Hippocampus.

[71]  J. Sirviö,et al.  The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats , 1995, Journal of neural transmission. Parkinson's disease and dementia section.